Literature DB >> 29847653

Epidemiology and Mortality-Related Prognostic Factors in Endophthalmitis.

Tzu-Heng Weng1, Hsu-Chieh Chang2,3, Chi-Hsiang Chung4,5, Fu-Huang Lin4, Ming-Cheng Tai1, Chang-Huei Tsao6, Ke-Hung Chien1,7, Wu-Chien Chien4,6.   

Abstract

Purpose: Endophthalmitis describes any intraocular inflammation that involves both the posterior and anterior segments and is divided into endogenous and exogenous types according to its pathogenesis. The incidence of endophthalmitis and its risk factors have been extensively evaluated. However, few studies have explored the mortality rate in patients diagnosed with endophthalmitis.
Methods: We obtained data entered into the National Health Insurance Research Database (NHIRD) from 2000 to 2013. The data collected included all discharge diagnoses of endophthalmitis in inpatients. Baseline characteristics, comorbidities, and prognostic factors were evaluated.
Results: This study identified 7764 patients who were diagnosed with endophthalmitis in Taiwan from 2000 to 2013. The mortality rate was 0.97% (75/7764), and the mean age was 63.57 ± 15.72 years. Epidemiological characteristics were compared as "with or without" for different systemic comorbidities, and the results indicated that the adjusted odds ratio (AOR) was significantly higher in cases comorbid with renal disease (AOR 2.864, P = 0.001), septicemia (AOR 8.886, P < 0.001), pneumonia (AOR 2.072, P = 0.030), and tumors (AOR 7.437, P < 0.001). However, comorbidity with diabetes mellitus (DM) lowered the AOR by 0.500-fold (P = 0.026). There was no significant difference in ORs between patients comorbid with hypertension, depression, anxiety, hyperlipidemia, thyrotoxicosis, liver disease, or injury (all P > 0.05). Conclusions: Among inpatients with endophthalmitis, predictors of mortality include renal disease, septicemia, pneumonia, neoplasia, a greater burden of comorbidity (especially catastrophic illness), longer hospital stays (more than 11 days), and higher medical costs. Interestingly, DM decreased the OR for inpatient mortality.

Entities:  

Mesh:

Year:  2018        PMID: 29847653     DOI: 10.1167/iovs.18-23783

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Mortality risk associated with endophthalmitis in West Virginia.

Authors:  Jeffrey Desilets; Chang Sup Lee; Wei Fang; David M Hinkle
Journal:  Int Ophthalmol       Date:  2021-04-16       Impact factor: 2.029

2.  The impact of diabetes mellitus medication on the incidence of endogenous endophthalmitis.

Authors:  Ke-Hung Chien; Ke-Hao Huang; Chi-Hsiang Chung; Yun-Hsiu Hsieh; Chang-Min Liang; Yu-Hua Chang; Tzu-Heng Weng; Wu-Chien Chien
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

3.  Association Between Endophthalmitis and the Incidence of Acute Coronary Syndrome in Patients With Ankylosing Spondylitis: A Nationwide, Population-Based Cohort Study.

Authors:  Ting-Yi Lin; Yi-Fen Lai; Wu-Chien Chien; Yi-Hao Chen; Chien-An Sun; Chi-Hsiang Chung; Jiann-Torng Chen; Ching-Long Chen
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

Review 4.  Emerging antimicrobial resistance and need for antimicrobial stewardship for ocular infections in India: A narrative review.

Authors:  Partha Biswas; Sneha Batra; Neha Gurha; Nitin Maksane
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

5.  Candida auris and endogenous panophthalmitis: clinical and histopathological features.

Authors:  Mark P Breazzano; Andrea A Tooley; Kyle J Godfrey; Codrin E Iacob; Nicolas A Yannuzzi; Harry W Flynn
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.